Eikon Therapeutics is pioneering a new method of drug discovery based on tracking and measuring
the movement of individual proteins in living cells.
Eikon’s live cell imaging drug discovery platform is built on groundbreaking innovations from its founders who pioneered the field of in vivo single-molecule microscopy, and whose work was awarded the Nobel Prize in Chemistry in 2014.
- Eric Betzig
- Robert Tjian
- Luke Lavis
- Xavier Darzacq
- We are thrilled to announce a new addition to our Board of Directors: Robin L. Washington. We are honored to have s… https://t.co/NAg2jQOpf7
- What's the future hold for #biotech in the Bay Area? Eikon CFO Freddie Bowie will join @SFBusinessTimes reporter… https://t.co/J0Sb9Pur7x
- What better way to build teamwork and a sense of community than to build bikes for children experiencing foster car… https://t.co/SWyMtKM1SD